Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

2seventy bio Q3 2024 GAAP EPS $(0.19) Beats $(0.22) Estimate, Sales $13.534M Miss $15.036M Estimate

Author: Benzinga Newsdesk | November 12, 2024 07:02am
2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. The company reported quarterly sales of $13.534 million which missed the analyst consensus estimate of $15.036 million by 9.99 percent. This is a 12.46 percent increase over sales of $12.034 million the same period last year.

Posted In: TSVT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist